首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >LIPID MICROEMULSION-BASED HYDROGELS FOR EFFECTIVE TOPICAL DELIVERY OF PHENYTOIN
【24h】

LIPID MICROEMULSION-BASED HYDROGELS FOR EFFECTIVE TOPICAL DELIVERY OF PHENYTOIN

机译:基于脂类微乳液的水可有效局部释放苯妥英

获取原文
           

摘要

Objective: Microemulsion is a promising drug delivery vehicle for lipophilic drugs but its acceptability for topical application is limited to its very low viscosity. The aim of the present study was to develop and characterize lipid microemulsion hydrogel as a topical drug carrier for phenytoin. Methods: Lipid oil-in-water (O/W) emulsions were formulated from palm kernel oil (PKO), coconut kernel oil (CKO) and soybean oil (SBO), and their blends using phase inversion temperature method. Stable nano-sized microemulsions were identified and formulated into phenytoin loaded hydrogels. The physicochemical properties of the formulations were evaluated in term of emulsion stability index, droplet size, zeta potential, pH, and rheological properties. The efficacy of in vitro drug release of phenytoin was further evaluated using Franz diffusion cells. Results: Stability study revealed that ten lipid emulsions mixing with surfactant Tween 80 at an oil-to-surfactant ratio of 1:9 having 100% emulsion stability indices. Among these, two emulsions (F6 and F21) were identified as the most stable nano-sized microemulsions with clear and transparent appearances; mean droplet size maintained within 100 nm (11–16 nm) as per stability study. Rheological data showed that all phenytoin is loaded hydrogels exhibited non-Newtonian and shear-thinning flow behavior, with high yield stress of a 10.3–18.8 Pa. The in vitro release profiles followed the first-order kinetic model, with R 2 >0.95, where F21 demonstrated the highest release rate, with 93.12% drug released in 12 h. Conclusion: These findings concluded that CKO/SBO blend microemulsion hydrogel has the highest potential for topical phenytoin delivery.
机译:目的:微乳剂是用于亲脂性药物的有前途的药物递送载体,但是其局部应用的可接受性限于其极低的粘度。本研究的目的是开发和表征脂质微乳液水凝胶作为苯妥英的局部药物载体。方法:采用相转化温度法,由棕榈仁油(PKO),椰子仁油(CKO)和大豆油(SBO)及其混合物配制脂质水包油(O / W)乳液。鉴定出稳定的纳米级微乳液,并将其配制成苯妥英钠负载的水凝胶。根据乳液稳定性指数,液滴大小,ζ电势,pH和流变学性质评估制剂的物理化学性质。使用Franz扩散池进一步评估了苯妥英钠的体外药物释放功效。结果:稳定性研究表明,十种脂质乳液与表面活性剂吐温80以油与表面活性剂的比例为1:9混合,具有100%的乳液稳定性指数。其中,两种乳液(F6和F21)被认为是最稳定的纳米微乳液,外观清晰透明。根据稳定性研究,平均液滴尺寸保持在100 nm(11-16 nm)以内。流变学数据表明,所有苯妥英钠负载的水凝胶均表现出非牛顿和剪切稀化的流动行为,高屈服应力为10.3-18.8 Pa。体外释放曲线遵循一阶动力学模型,R 2> 0.95,其中F21的释放率最高,在12小时内释放了93.12%的药物。结论:这些发现得出结论,CKO / SBO共混微乳水凝胶具有最高的局部苯妥英钠释放潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号